Showing results (11-20 of 370) with videos related to

Sort By:
Pageof 37
Journal of the National Comprehensive Cancer Network : JNCCN|April 6, 2011
Multigene sets for clinical application in gliomaJohn F de Groot, Erik P Sulman, Kenneth D Aldape
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2009
Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapyAgda K Lucio-Eterovic, Yuji Piao, John F de Groot
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 27, 2020
Impact of adverse events of bevacizumab on survival outcomes of patients with recurrent glioblastomaCarlos Kamiya-Matsuoka, Mohamed A Hamza, John F de Groot
Neurologic Clinics|April 15, 2003
Spinal cord compressionDavid Schiff
Cancer Investigation|October 24, 2007
Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiationDavid Schiff
Journal of Neurosurgery|December 16, 2004
Gliomas following organ transplantation: analysis of the contents of a tumor registryDavid Schiff
Continuum (Minneapolis, Minn.)|December 5, 2017
Low-grade GliomasDavid Schiff
Continuum (Minneapolis, Minn.)|April 4, 2015
Low-grade gliomasDavid Schiff
Neurology|July 15, 2024
Low-Grade Gliomas: A New Mutation, New Targeted Therapy, and Many QuestionsDavid Schiff
Hematology/Oncology Clinics of North America|November 10, 2021
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including GlioblastomaEvanthia Galanis, Patrick Y Wen, John F de Groot, et al.
Pageof 37